Owkin and CRO Aviano Sign Master Partnership Agreement to Foster Collaborative Oncology Research
Owkin official newsroom · 行业原文收录 · 来源发布：Fri Aug 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:09:15 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
PARIS & PORDENONE, Italy — Owkin, the agentic AI company pioneering the first autonomous AI scientist to revolutionize drug discovery and development, and the Centro di Riferimento Oncologico di Aviano (CRO), a leading Italian National Cancer Institute (IRCCS) dedicated to research and care, today announced the signature of a Master Partnership Agreement aimed at facilitating connections and colla
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。